Will better neurotech regulations be enough to address privacy, effectiveness and potential harm concerns?

By Alvaro Fernandez | March 12, 2020

How to address pri­va­cy, eth­i­cal and reg­u­la­to­ry issues: Exam­ples in cog­ni­tive enhance­ment, depres­sion and ADHD from Sharp­Brains See above the fas­ci­nat­ing pre­sen­ta­tions by Dr. Anna Wexler, Dr. Karen Rom­melfanger and Jacque­line Stud­er on pri­va­cy and ethics dur­ing the 2019 Sharp­Brains Vir­tu­al Sum­mit. We still lack clear stan­dards and tax­onomies for neu­rotech­nol­o­gy but sev­er­al ini­tia­tives are…

Read More